After months of speculation and years of debate, the U.S. Food and Drug Administration (FDA) today issued a final regulation classifying dental amalgam and its component parts as class II medical devices -- even as the agency insists that amalgam poses no health risks.
FDA follows through on plan to reclassify dental amalgam
Jul 27, 2009
Latest in Regulatory Updates
FDA approves first OTC acetaminophen-naproxen combo pill
August 19, 2026
Action for Dental Health Act advances in Congress
August 6, 2026
Velmeni for Dentists 3D gets FDA nod
July 30, 2026
U.S. judge rules against state advertising rule
July 29, 2026



















